BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37820648)

  • 1. [Complications of liver cirrhosis].
    Reincke M; Thimme R; Schultheiß M
    Dtsch Med Wochenschr; 2023 Oct; 148(21):1371-1382. PubMed ID: 37820648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and complications associated with cirrhosis of the liver.
    Poordad FF
    Curr Med Res Opin; 2015 May; 31(5):925-37. PubMed ID: 25697811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Liver Injury and Decompensated Cirrhosis.
    Crismale JF; Friedman SL
    Med Clin North Am; 2020 Jul; 104(4):647-662. PubMed ID: 32505258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal hypertension and its complications--an overview.
    Resnick RH
    J Clin Gastroenterol; 1980 Sep; 2(3):259-67. PubMed ID: 7005312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis and Portal Hypertension in the Pediatric Population.
    Chapin CA; Bass LM
    Clin Liver Dis; 2018 Nov; 22(4):735-752. PubMed ID: 30266160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and perspectives of diagnosis and treatment of complications related to liver cirrhosis].
    Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):241-245. PubMed ID: 28494539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status and prospects of integrated traditional Chinese and Western medicine for treatment of portal hypertension].
    Wang J; Zhu XN; Zhang YR; Gao YQ; Yang YP
    Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):249-253. PubMed ID: 29996333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The portal hypertension syndrome: etiology, classification, relevance, and animal models.
    Bosch J; Iwakiri Y
    Hepatol Int; 2018 Feb; 12(Suppl 1):1-10. PubMed ID: 29064029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal hypertension as we see it.
    Smith GW; Maddrey WC; Zuidema GD
    Major Probl Clin Surg; 1974; 14(0):1-35. PubMed ID: 4604923
    [No Abstract]   [Full Text] [Related]  

  • 11. Portal Hypertension and Related Complications: Diagnosis and Management.
    Simonetto DA; Liu M; Kamath PS
    Mayo Clin Proc; 2019 Apr; 94(4):714-726. PubMed ID: 30947834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M; Simón-Talero M; Römer J; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Maurer MH; Zipprich A; Triolo M; Maleux G; Fialla AD; Dam C; Vidal-González J; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; López M; Jansen C; Chang J; Schierwagen R; Uschner F; Kukuk G; Meyer C; Thomas D; Wolter K; Strassburg CP; Laleman W; La Mura V; Ripoll C; Berzigotti A; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Krag A; Genescà J; Trebicka J;
    J Hepatol; 2020 Jun; 72(6):1140-1150. PubMed ID: 31954206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Management of the Complications of Cirrhosis and Portal Hypertension: Variceal Hemorrhage, Ascites, and Spontaneous Bacterial Peritonitis.
    Garcia-Tsao G
    Dig Dis; 2016; 34(4):382-6. PubMed ID: 27170392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and future pharmacological therapies for managing cirrhosis and its complications.
    Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
    World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of liver diseases in Korea: liver cirrhosis.
    Jang JW
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S40-9. PubMed ID: 20037279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of portal hypertension on prognosis in patients with decompensated liver cirrhosis].
    Zhang JY; Kuai JH; Jia JD; Wang BE; Qin CY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):263-5. PubMed ID: 19403023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.
    D'Amico G; Morabito A; D'Amico M; Pasta L; Malizia G; Rebora P; Valsecchi MG
    Hepatol Int; 2018 Feb; 12(Suppl 1):34-43. PubMed ID: 28681347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of end-stage liver disease.
    Liou IW
    Med Clin North Am; 2014 Jan; 98(1):119-52. PubMed ID: 24266918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Portal hypertension in cirrhoses: mechanisms, symptomatology and complications].
    Buffet C
    Rev Prat; 1990 Jun; 40(16):1454-7. PubMed ID: 2359944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current situation of screening, prevention and treatment of bleeding esophageal varices in cirrhotic portal hypertension in Tibet region: a multicenter study].
    Huan H; Liu C; Yang Z; Bao JL; Liu C; Wang JT; Zhang L; Wang CH; Ci RSP; Tu QL; Ren T; Xu D; Zhang HJ; Li XG; Kang N; Li XP; Wu YH; Pu X; Tan YJ; Cao JJ; Luo SWQ; Luo SQP; Zhuo M; Qi XL
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):737-741. PubMed ID: 33053972
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.